Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana

Exclusion Criteria

• •If child has previously had intussusception or abdominal surgery.
• •Use of any immunosuppressive drugs or immunoglobulin and/or blood product use since birth or anticipated during study period.
• •Current enrollment in any other intervention trial or use of any investigational drug or vaccine throughout the study period.
• •Birthweight less than 2000 grams or gestation \< 36 weeks, if this information is available.
• •Any subject who reports plan to leave the study area before the completion of the study (i.e., relocation, migration, etc.).
• •Another child living in the same compound is already enrolled in the trial (i.e., only one participant can be enrolled per compound).
• •After the rotavirus vaccine is introduced into the routine EPI system in Navrongo: Another child in the compound is less than 16 weeks of age.
• •The child has received rotavirus vaccine outside of this study.